APO Research

APO RESEARCH · REPORT

Azithromycin

Selected research

Market Structure

Global Azithromycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Azithromycin market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Azithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Azithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Azithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Azithromycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Azithromycin include Teva, Sandoz, Mylan, Zydus Pharmaceuticals, Pfizer, Anke Hengyi, Hainan Poly Pharm, Hainan Hailing Chemipharma Corporation and Wockhardt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Azithromycin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Azithromycin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Azithromycin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Azithromycin market size, projected growth trends, production technologies, key applications, and end-use industries.

Azithromycin Segment by Company

Teva

Sandoz

Mylan

Zydus Pharmaceuticals

Pfizer

Anke Hengyi

Hainan Poly Pharm

Hainan Hailing Chemipharma Corporation

Wockhardt

Gland Pharma

CSPC Ouyi Pharmaceutical

Aurobindo Pharma

Akorn

Azithromycin Segment by Type

Injectables

Ophthalmics

Oral

Azithromycin Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Azithromycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azithromycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azithromycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azithromycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Azithromycin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Azithromycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Azithromycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Azithromycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Azithromycin Industry Trends Table 2. Azithromycin Industry Drivers Table 3. Azithromycin Industry Opportunities and Challenges Table 4. Azithromycin Industry Restraints Table 5. Global Azithromycin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Azithromycin Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Azithromycin Sales by Manufacturers (kg) & (2021-2026) Table 8. Global Azithromycin Sales Market Share by Manufacturers Table 9. Global Azithromycin Average Sales Price (US$/g) of Manufacturers (2021-2026) Table 10. Global Azithromycin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Azithromycin Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Azithromycin Manufacturers, Product Type & Application Table 13. Global Azithromycin Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Azithromycin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injectables Table 17. Major Manufacturers of Ophthalmics Table 18. Major Manufacturers of Oral Table 19. Global Azithromycin Sales by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Azithromycin Sales by Type (2021-2026) & (kg) Table 21. Global Azithromycin Sales by Type (2027-2032) & (kg) Table 22. Global Azithromycin Sales Market Share by Type (2021-2026) Table 23. Global Azithromycin Sales Market Share by Type (2027-2032) Table 24. Global Azithromycin Revenue by Type 2021 VS 2025 VS 2032 (kg) Table 25. Global Azithromycin Revenue by Type (2021-2026) & (kg) Table 26. Global Azithromycin Revenue by Type (2027-2032) & (kg) Table 27. Global Azithromycin Revenue Market Share by Type (2021-2026) Table 28. Global Azithromycin Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Retail Pharmacies Table 30. Major Manufacturers of Online Pharmacies Table 31. Major Manufacturers of Hospital Pharmacies Table 32. Global Azithromycin Sales by Application 2021 VS 2025 VS 2032 (kg) Table 33. Global Azithromycin Sales by Application (2021-2026) & (kg) Table 34. Global Azithromycin Sales by Application (2027-2032) & (kg) Table 35. Global Azithromycin Sales Market Share by Application (2021-2026) Table 36. Global Azithromycin Sales Market Share by Application (2027-2032) Table 37. Global Azithromycin Revenue by Application 2021 VS 2025 VS 2032 (kg) Table 38. Global Azithromycin Revenue by Application (2021-2026) & (kg) Table 39. Global Azithromycin Revenue by Application (2027-2032) & (kg) Table 40. Global Azithromycin Revenue Market Share by Application (2021-2026) Table 41. Global Azithromycin Revenue Market Share by Application (2027-2032) Table 42. Global Azithromycin Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 43. Global Azithromycin Sales by Region (2021-2026) & (kg) Table 44. Global Azithromycin Sales Market Share by Region (2021-2026) Table 45. Global Azithromycin Sales Forecasted by Region (2027-2032) & (kg) Table 46. Global Azithromycin Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 48. North America Azithromycin Sales by Country (2021-2026) & (kg) Table 49. North America Azithromycin Sales by Country (2027-2032) & (kg) Table 50. Europe Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 51. Europe Azithromycin Sales by Country (2021-2026) & (kg) Table 52. Europe Azithromycin Sales by Country (2027-2032) & (kg) Table 53. Asia Pacific Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 54. Asia Pacific Azithromycin Sales by Country (2021-2026) & (kg) Table 55. Asia Pacific Azithromycin Sales by Country (2027-2032) & (kg) Table 56. South America, Middle East and Africa Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 57. South America, Middle East and Africa Azithromycin Sales by Country (2021-2026) & (kg) Table 58. South America, Middle East and Africa Azithromycin Sales by Country (2027-2032) & (kg) Table 59. Global Azithromycin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Azithromycin Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Azithromycin Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Azithromycin Revenue Market Share by Region (2021-2026) Table 63. Global Azithromycin Revenue Market Share by Region (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Azithromycin Product Portfolio Table 68. Teva Recent Development Table 69. Sandoz Company Information Table 70. Sandoz Business Overview Table 71. Sandoz Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sandoz Azithromycin Product Portfolio Table 73. Sandoz Recent Development Table 74. Mylan Company Information Table 75. Mylan Business Overview Table 76. Mylan Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Mylan Azithromycin Product Portfolio Table 78. Mylan Recent Development Table 79. Zydus Pharmaceuticals Company Information Table 80. Zydus Pharmaceuticals Business Overview Table 81. Zydus Pharmaceuticals Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Zydus Pharmaceuticals Azithromycin Product Portfolio Table 83. Zydus Pharmaceuticals Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pfizer Azithromycin Product Portfolio Table 88. Pfizer Recent Development Table 89. Anke Hengyi Company Information Table 90. Anke Hengyi Business Overview Table 91. Anke Hengyi Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Anke Hengyi Azithromycin Product Portfolio Table 93. Anke Hengyi Recent Development Table 94. Hainan Poly Pharm Company Information Table 95. Hainan Poly Pharm Business Overview Table 96. Hainan Poly Pharm Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Hainan Poly Pharm Azithromycin Product Portfolio Table 98. Hainan Poly Pharm Recent Development Table 99. Hainan Hailing Chemipharma Corporation Company Information Table 100. Hainan Hailing Chemipharma Corporation Business Overview Table 101. Hainan Hailing Chemipharma Corporation Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hainan Hailing Chemipharma Corporation Azithromycin Product Portfolio Table 103. Hainan Hailing Chemipharma Corporation Recent Development Table 104. Wockhardt Company Information Table 105. Wockhardt Business Overview Table 106. Wockhardt Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Wockhardt Azithromycin Product Portfolio Table 108. Wockhardt Recent Development Table 109. Gland Pharma Company Information Table 110. Gland Pharma Business Overview Table 111. Gland Pharma Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Gland Pharma Azithromycin Product Portfolio Table 113. Gland Pharma Recent Development Table 114. CSPC Ouyi Pharmaceutical Company Information Table 115. CSPC Ouyi Pharmaceutical Business Overview Table 116. CSPC Ouyi Pharmaceutical Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. CSPC Ouyi Pharmaceutical Azithromycin Product Portfolio Table 118. CSPC Ouyi Pharmaceutical Recent Development Table 119. Aurobindo Pharma Company Information Table 120. Aurobindo Pharma Business Overview Table 121. Aurobindo Pharma Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Aurobindo Pharma Azithromycin Product Portfolio Table 123. Aurobindo Pharma Recent Development Table 124. Akorn Company Information Table 125. Akorn Business Overview Table 126. Akorn Azithromycin Sales (kg), Price (US$/g), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Akorn Azithromycin Product Portfolio Table 128. Akorn Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Azithromycin Distributors List Table 132. Azithromycin Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Azithromycin Product Image Figure 2. Global Azithromycin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azithromycin Market Size (2021-2032) & (US$ Million) Figure 4. Global Azithromycin Sales (2021-2032) & (kg) Figure 5. Global Azithromycin Average Price (US$/g) & (2021-2032) Figure 6. Global Top 5 and 10 Azithromycin Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injectables Image Figure 9. Ophthalmics Image Figure 10. Oral Image Figure 11. Global Azithromycin Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Azithromycin Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Azithromycin Sales Market Share by Type (2021-2032) Figure 14. Global Azithromycin Revenue by Type (2021 VS 2025 VS 2032) & (kg) Figure 15. Global Azithromycin Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Azithromycin Revenue Market Share by Type (2021-2032) Figure 17. Retail Pharmacies Image Figure 18. Online Pharmacies Image Figure 19. Hospital Pharmacies Image Figure 20. Global Azithromycin Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 21. Global Azithromycin Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Azithromycin Sales Market Share by Application (2021-2032) Figure 23. Global Azithromycin Revenue by Application (2021 VS 2025 VS 2032) & (kg) Figure 24. Global Azithromycin Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Azithromycin Revenue Market Share by Application (2021-2032) Figure 26. North America Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 27. North America Azithromycin Sales Market Share by Country (2021-2032) Figure 28. U.S. Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 29. Canada Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 30. Mexico Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 31. Europe Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 32. Europe Azithromycin Sales Market Share by Country (2021-2032) Figure 33. Germany Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 34. France Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 35. U.K. Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 36. Italy Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 37. Netherlands Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 38. Asia Pacific Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 39. Asia Pacific Azithromycin Sales Market Share by Country (2021-2032) Figure 40. China Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 41. Japan Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 42. South Korea Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 43. Southeast Asia Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 44. India Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 45. Australia Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 46. South America, Middle East and Africa Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 47. South America, Middle East and Africa Azithromycin Sales Market Share by Country (2021-2032) Figure 48. Brazil Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 49. South Africa Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 50. Saudi Arabia Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 51. Turkey Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 52. Argentina Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 53. UAE Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 54. Egypt Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 55. Chile Azithromycin Sales and Growth Rate (2021-2032) & (kg) Figure 56. Global Azithromycin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Azithromycin Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Azithromycin Revenue (2021-2032) & (US$ Million) Figure 59. North America Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Azithromycin Revenue (2021-2032) & (US$ Million) Figure 61. Europe Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Azithromycin Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Azithromycin Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Azithromycin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Azithromycin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injectables
  • Ophthalmics
  • Oral
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Teva
  • Sandoz
  • Mylan
  • Zydus Pharmaceuticals
  • Pfizer
  • Anke Hengyi
  • Hainan Poly Pharm
  • Hainan Hailing Chemipharma Corporation
  • Wockhardt
  • Gland Pharma
  • CSPC Ouyi Pharmaceutical
  • Aurobindo Pharma
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Azithromycin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Azithromycin Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Azithromycin Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Azithromycin Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Azithromycin Market Dynamics
  1. 2.1 Azithromycin Industry Trends
  2. 2.2 Azithromycin Industry Drivers
  3. 2.3 Azithromycin Industry Opportunities and Challenges
  4. 2.4 Azithromycin Industry Restraints
3 Azithromycin Market by Manufacturers
  1. 3.1 Global Azithromycin Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Azithromycin Sales by Manufacturers (2021-2026)
  3. 3.3 Global Azithromycin Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Azithromycin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Azithromycin Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Azithromycin Manufacturers, Product Type & Application
  7. 3.7 Global Azithromycin Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Azithromycin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Azithromycin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Azithromycin Tier 1, Tier 2, and Tier 3
4 Azithromycin Market by Type
  1. 4.1 Azithromycin Type Introduction
  2. 4.1.1 Injectables
  3. 4.1.2 Ophthalmics
  4. 4.1.3 Oral
  5. 4.2 Global Azithromycin Sales by Type
  6. 4.2.1 Global Azithromycin Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Azithromycin Sales by Type (2021-2032)
  8. 4.2.3 Global Azithromycin Sales Market Share by Type (2021-2032)
  9. 4.3 Global Azithromycin Revenue by Type
  10. 4.3.1 Global Azithromycin Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Azithromycin Revenue by Type (2021-2032)
  12. 4.3.3 Global Azithromycin Revenue Market Share by Type (2021-2032)
5 Azithromycin Market by Application
  1. 5.1 Azithromycin Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Azithromycin Sales by Application
  6. 5.2.1 Global Azithromycin Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Azithromycin Sales by Application (2021-2032)
  8. 5.2.3 Global Azithromycin Sales Market Share by Application (2021-2032)
  9. 5.3 Global Azithromycin Revenue by Application
  10. 5.3.1 Global Azithromycin Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Azithromycin Revenue by Application (2021-2032)
  12. 5.3.3 Global Azithromycin Revenue Market Share by Application (2021-2032)
6 Global Azithromycin Sales by Region
  1. 6.1 Global Azithromycin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Azithromycin Sales by Region (2021-2032)
  3. 6.2.1 Global Azithromycin Sales by Region (2021-2026)
  4. 6.2.2 Global Azithromycin Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Azithromycin Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Azithromycin Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Azithromycin Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Azithromycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Azithromycin Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Azithromycin Revenue by Region
  1. 7.1 Global Azithromycin Revenue by Region
  2. 7.1.1 Global Azithromycin Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Azithromycin Revenue by Region (2021-2026)
  4. 7.1.3 Global Azithromycin Revenue by Region (2027-2032)
  5. 7.1.4 Global Azithromycin Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Azithromycin Revenue (2021-2032)
  8. 7.2.2 North America Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Azithromycin Revenue (2021-2032)
  11. 7.3.2 Europe Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Azithromycin Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Azithromycin Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Azithromycin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Azithromycin Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Azithromycin Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Azithromycin Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Zydus Pharmaceuticals
  20. 8.4.1 Zydus Pharmaceuticals Company Information
  21. 8.4.2 Zydus Pharmaceuticals Business Overview
  22. 8.4.3 Zydus Pharmaceuticals Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zydus Pharmaceuticals Azithromycin Product Portfolio
  24. 8.4.5 Zydus Pharmaceuticals Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Azithromycin Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Anke Hengyi
  32. 8.6.1 Anke Hengyi Company Information
  33. 8.6.2 Anke Hengyi Business Overview
  34. 8.6.3 Anke Hengyi Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Anke Hengyi Azithromycin Product Portfolio
  36. 8.6.5 Anke Hengyi Recent Developments
  37. 8.7 Hainan Poly Pharm
  38. 8.7.1 Hainan Poly Pharm Company Information
  39. 8.7.2 Hainan Poly Pharm Business Overview
  40. 8.7.3 Hainan Poly Pharm Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hainan Poly Pharm Azithromycin Product Portfolio
  42. 8.7.5 Hainan Poly Pharm Recent Developments
  43. 8.8 Hainan Hailing Chemipharma Corporation
  44. 8.8.1 Hainan Hailing Chemipharma Corporation Company Information
  45. 8.8.2 Hainan Hailing Chemipharma Corporation Business Overview
  46. 8.8.3 Hainan Hailing Chemipharma Corporation Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hainan Hailing Chemipharma Corporation Azithromycin Product Portfolio
  48. 8.8.5 Hainan Hailing Chemipharma Corporation Recent Developments
  49. 8.9 Wockhardt
  50. 8.9.1 Wockhardt Company Information
  51. 8.9.2 Wockhardt Business Overview
  52. 8.9.3 Wockhardt Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Wockhardt Azithromycin Product Portfolio
  54. 8.9.5 Wockhardt Recent Developments
  55. 8.10 Gland Pharma
  56. 8.10.1 Gland Pharma Company Information
  57. 8.10.2 Gland Pharma Business Overview
  58. 8.10.3 Gland Pharma Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Gland Pharma Azithromycin Product Portfolio
  60. 8.10.5 Gland Pharma Recent Developments
  61. 8.11 CSPC Ouyi Pharmaceutical
  62. 8.11.1 CSPC Ouyi Pharmaceutical Company Information
  63. 8.11.2 CSPC Ouyi Pharmaceutical Business Overview
  64. 8.11.3 CSPC Ouyi Pharmaceutical Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 CSPC Ouyi Pharmaceutical Azithromycin Product Portfolio
  66. 8.11.5 CSPC Ouyi Pharmaceutical Recent Developments
  67. 8.12 Aurobindo Pharma
  68. 8.12.1 Aurobindo Pharma Company Information
  69. 8.12.2 Aurobindo Pharma Business Overview
  70. 8.12.3 Aurobindo Pharma Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aurobindo Pharma Azithromycin Product Portfolio
  72. 8.12.5 Aurobindo Pharma Recent Developments
  73. 8.13 Akorn
  74. 8.13.1 Akorn Company Information
  75. 8.13.2 Akorn Business Overview
  76. 8.13.3 Akorn Azithromycin Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Akorn Azithromycin Product Portfolio
  78. 8.13.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Azithromycin Value Chain Analysis
  2. 9.1.1 Azithromycin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Azithromycin Production Mode & Process
  6. 9.2 Azithromycin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Azithromycin Distributors
  9. 9.2.3 Azithromycin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research